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Carvedilol is a non-selective beta-blocker indicated in the treatment of mild to mode-
rate congestive heart failure. It is a basic, lipophilic compound. Being categorized as
Class II compound as per the BCS classification system, it possesses very poor oral bio-
availability and shows significant first pass metabolism (1). Thus, a strategy to improve
bioavailability should aim at improving its aqueous solubility and overcoming first pass
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The purpose of this study was to improve the solubility
and dissolution rate of carvedilol by forming a ternary
complex with b-cyclodextrin and citric acid and to for-
mulate its mouth-dissolving tablets. The rationale for pre-
paring mouth-dissolving tablet of carvedilol was to make
the drug available in a soluble form in the mouth, which
would facilitate its absorption from the buccal cavity. This
would help to overcome its first-pass metabolism and the-
reby improve bioavailability. Phase solubility studies re-
vealed the ability of b-cyclodextrin and citric acid to comp-
lex with carvedilol and significantly increase its solubility.
Ternary complexation of carvedilol was carried out with b-cy-
clodextrin and citric acid by physical mixing, kneading
and spray drying methods and the prepared complexes
were characterized by Fourier transform infra red spectro-
scopy, differential scanning calorimetry, powder X-ray
diffractometry, scanning electron microscopy and com-
plexation efficiency. The complex obtained by the spray
drying method resulted in highest complexation efficiency
and a 110-fold increase in the solubility of carvedilol. The
mouth-dissolving tablets formulated using the spray dried
complex with suitable excipients showed 100 % dissolu-
tion within five minutes. Accelerated stability studies of
mouth-dissolving tablets carried out as per ICH guide-
lines revealed that the tablets were stable.
Keywords: carvedilol, cyclodextrin, citric acid, ternary com-
plex, solubility, spray drying, mouth-dissolving tablet
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metabolism. Innovative drug delivery systems known as »melt in mouth« or »mouth di-
ssolve tablets« are novel types of tablets that disintegrate/disperse/dissolve in saliva.
Their characteristic advantage, such as administration without water anywhere anytime,
leads to their suitability for geriatric and pediatric patients. They are also most suitable
for drugs that undergo extensive fist pass metabolism. The benefits, in terms of patient
compliance, rapid onset of action as the drug goes directly into systemic circulation and
good stability, make these tablets popular as a dosage form of choice on the current mar-
ket. However, a major challenge is to develop mouth-dissolving tablets of poorly soluble
drugs (2).
Of the various approaches to improve drug solubility, complexation with cyclodex-
trin is being widely explored. Cyclodextrins are powerful carriers for improving the the-
rapeutic efficacy of drugs with poor aqueous solubility through inclusion complexes.
However, exploitation of this cyclodextrin property is hindered by the relatively low
water solubility and high molecular mass of natural cyclodextrin (3, 4). Among the strate-
gies proposed for this aim, addition of suitable auxiliary substances can be a valuable
approach to increase the cyclodextrin solubilization capacity. It has been reported that
certain low molecular mass acids or hydroxyl acids e.g., citric acid, tartaric acid, can
strongly enhance the cyclodextrin solubilizing power towards basic drugs as a result of
the combined effect of salt formation and inclusion complexation (5, 6).
The purpose of this study was to investigate a dual approach by forming an inclu-
sion complex along with an appropriate salt form of carvedilol in order to improve its
aqueous solubility and dissolution rate.
EXPERIMENTAL
Materials
Carvedilol was a generous gift from M/s Symed Labs (India). b-cyclodextrin was
purchased from M/s ISP Ltd. (Hong Kong). Citric acid, potassium dihydrogen phospha-
te, sodium hydroxide, calcium chloride were supplied by M/s Merck Ltd. (India). All
other reagents and solvents used were of analytical grade.
Analysis of carvedilol using a UV-visible spectrophotometer
First, 100 mg mL–1 stock solution of carvedilol was prepared in methanol and further
dilutions were made in distilled water ranging from 5–30 mg mL–1. The calibration curve
was obtained by recording the absorbance on a UV spectrophotometer (Jasco V350, Japan)
at 285 nm (7). Linearity in the calibration curve was observed with regression R2 = 0.9995.
Phase solubility studies with b-cyclodextrin
An excess of drug was added to 10 mL of b-cyclodextrin aqueous solution (1–5
mmol L–1) in a stoppered conical flask and shaken at room temperature on a magnetic
stirrer. At equilibrium after 2 days, aliquots were withdrawn, centrifuged at 4000 rpm
122
V. Pokharkar et al.: Ternary complexation of carvedilol, b-cyclodextrin and citric acid for mouth-dissolving tablet formulation, Acta
Pharm. 59 (2009) 121–132.
for 10 minutes, filtered (0.22-mm pore size, Whatman, UK) and spectrophotometrically
assayed for drug content at 285 nm.
Phase solubility studies with b-cyclodextrin and citric acid
An excess of drug was added to 10 mL aqueous solution containing citric acid (1–4
mmol L–1) and 2 mmol L–1 of b-cyclodextrin in a stoppered conical flask and shaken at
room temperature on a magnetic stirrer. At equilibrium after 2 days, aliquots were with-
drawn, centrifuged at 4000 rpm for 10 minutes, filtered (0.22-mm pore size, Whatman)
and spectrophotometrically assayed for drug content at 285 nm.
Preparation of ternary complexes
Carvedilol, b-cyclodextrin and citric acid ternary complexes were prepared at 1:2:2
molar ratios, respectively, as described in detail below.
Physical mixture (PM). – For physical mixtures, carvedilol, b-cyclodextrin and citric
acid were weighed accurately, mixed thoroughly by trituration in a mortar and sieved
through a 0.25-mm sieve. All physical mixtures were stored in a dessicator until further
evaluation.
Kneaded complex (KC). – The kneaded complex of carvedilol, b-cyclodextrin and cit-
ric acid was prepared by wetting the physical mixture in a mortar with a minimum vol-
ume of ethanol/water mixture (15/85, V/V) and kneading thoroughly with a pestle to
obtain a paste, which was then dried under vacuum at room temperature, sieved
through a 0.25-mm sieve and stored in a dessicator until further evaluation.
Spray dried complex (SDC). – A mixture of carvedilol, b-cyclodextrin and citric acid
was dissolved in ethanol/water (15/85, V/V). The resultant clear solution was kept for
stirring on a magnetic stirrer for 48 hours at room temperature so as to attain comple-
xation equilibrium. Spray drying was carried out using a laboratory scale spray dryer
(Jay Instruments and System Pvt. Ltd., India) under the following set of conditions: inlet
temperature 112 °C, outlet temperature 55 °C, atomization air pressure 100 kPa, aspira-
tion pressure –2.5 kPa, flow rate 12 mL min–1. The powder sample was sieved through a
0.25-mm sieve and stored in a dessicator until further evaluation.
Estimation of free and complexed drug
The inclusion yield of complexes was determined by dissolving 10 mg of the com-
plex in 10 mL anhydrous acetonitrile for estimation of free drug and another 10 mg of
complex in 10 mL acetonitrile/water solution (1:1) for estimation of total drug. The solu-
tions were centrifuged at 4000 rpm for 10 minutes, filtered (0.22-mm pore size, What-
man) and spectrophotometrically assayed for drug content at 285 nm.
Differential scanning calorimetry (DSC)
DSC studies were carried out using differential scanning calorimetry equipped with
an intracooler (DSC 821e, Mettler Toledo, Switzerland). Indium/zinc standards were used
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to calibrate the DSC temperature and enthalpy scale. The drug and drug complex were
hermetically sealed in aluminum pans and heated at a constant rate of 10 °C min–1 over
a temperature range of 25 to 225 °C; inert atmosphere was maintained by purging nitro-
gen gas at a flow rate of 50 mL min–1.
Powder X-ray diffractometry (PXRD)
PXRD patterns were recorded on an X-ray diffractometer (PW 1729, Philips, The Ne-
therlands). The samples were irradiated with monochromatized Cu-k ∞ radiation and
analyzed between 2 to 70 oq. The voltage and current used were 30 kV and 30 mA, res-
pectively.
Scanning electron microscopy (SEM)
Samples were coated with a thin gold-palladium layer using a sputter coater unit
(VG-Microtech, UK) and the surface topography was analyzed with a Cambridge Ste-
reoscan 120 scanning electron microscope (SEM, Cambridge, UK) operated at an accelera-
tion voltage of 15 kV.
Fourier transform infrared spectroscopy (FTIR)
FTIR spectroscopy was performed on a Fourier Transform Infrared Spectrometer (JASCO,
V 5300, Japan). Pellets of the drug sample in KBr were prepared on KBr press (Spectra
Lab, India). The spectra were scanned over a wavenumber range of 4000 to 400 cm–1.
Saturation solubility of the complex
Saturation solubility of the complexes was determined by equilibrating an excess of
complex in different media such as 0.1 mol L–1 HCl (pH 1.2), acetate buffer (pH 4.5),
simulated saliva (pH 6.2), and distilled water for 48 hours on a mechanical shaker at
room temperature. At equilibrium after 2 days, aliquots were withdrawn, followed by
centrifugation at 4000 rpm for 10 minutes, filtration (0.22-mm pore size, Whatman) and a
spectrophotometric assay for drug content at 285 nm.
Preparation of mouth-dissolving tablets
All formulations of pure carvedilol or carvedilol complex (equivalent to 6.25 mg of
carvedilol) were compressed into tablets using a 10-station, single rotary, B-tooling tab-
let machine (M/s Rimek Tabletting Machine, MINI PRESS-I, B-tooling, Karnawati Engi-
neering Ltd, India) using a flat face bevel edged 11-mm die and punch set. Tabletting ex-
cipients such as lactose monohydrate, microcrystalline cellulose (Avicel pH 102), mannitol,
saccharine, crosspovidone (super disintegrant) or magnesium stearate were added as per
the composition given in Table I. Tablets were prepared by the wet granulation method
using water as a granulating agent. The prepared tablets were evaluated for mass varia-
tion, hardness, friability, content uniformity, disintegration time and in vitro dissolution.
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In vitro dissolution studies
Dissolution studies were performed using a USP 27 (8) type II dissolution test appa-
ratus (TDT-06P, Electrolab, India) in distilled water. Tablets of different formulations were
placed in a dissolution vessel containing 900 mL medium maintained at 37 ± 0.5 °C and
stirred at 50 rpm. Samples were collected periodically and were replaced with fresh dis-
solution medium. Collected samples were filtered through Whatman filter paper. Con-
centration of carvedilol was determined spectrophotometrically at 285 nm.
Stability studies
The accelerated stability study of prepared tablets was carried out as per ICH gui-
delines at 40 °C/75 % RH for up to 3 months. Samples were removed and evaluated for
mass variation, hardness, friability, content uniformity, disintegration time, dissolution,
PXRD and DSC studies.
RESULTS AND DISCUSSION
Phase solubility studies
The phase-solubility diagram for complex formation between carvedilol and b-cy-
clodextrin is presented in Fig. 1. According to the Higuchi and Connors classification
(9), the diagram shows the AN type curve where the solubility increases linearly with
cyclodextrin concentration and further deviates negatively at higher cyclodextrin con-
centrations. The interaction mechanism for the AN type curve is complicated because of
a significant contribution of solute-solvent interaction to the complexation. The negative
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Table I. Composition of carvedilol complex tablets
Sample No. Component Mass per tablet (mg)
Intragranular portion
1








7 Water (granulating solution) q.s.
Extragranular portion
8 Crospovidone 6.00
9 Magnesium stearate 2.00
Total mass of tablet 150.00
deviation from linearity may be associated with cyclodextrin induced changes in the di-
electric constant of the aqueous complexation media, changes in complex solubility or
self-association of cyclodextrin molecules. It can be seen from the curve, that the appar-
ent solubility of carvedilol increased linearly due to the formation of a soluble inclusion
complex between carvedilol and b-cyclodextrin. Earlier Wen et al. (10) reported a similar
AN type curve and further concluded from the fluorescence study that carvedilol forms
a 1:2 complex with b-cyclodextrin.
The phase solubility diagram of carvedilol with b-cyclodextrin and citric acid (Fig.
1) illustrates the AN type of curve. The addition of citric acid along with b-cyclodextrin
resulted in an increase in solubility of carvedilol to a much greater extent compared to
complexation of the drug with b-cyclodextrin alone. This may be attributed to the fact
that organic hydroxyl acids such as citric acid are able to enhance the solubility of the
basic guest molecule both by forming a salt and by increasing the stability constant of
the complex (11). Thus the addition of citric acid results in formation of carvedilol citrate
salt (6).
Estimation of free and complexed drug content
The complexation efficiency, i.e., the inclusion yield of the drug in b-cyclodextrin
was determined based on the differential solubility of free drug and complexed drug
(12). The amount of complexed drug was the highest in the case of the complex obtained
by the spray drying method (83.2 ± 0.6 %) compared to the kneaded complex (68.7 ± 1.1
%) and physical mixture (3.4 ± 1.0 %) (n = 3). This indicated that the drug in the physical
mixture remained essentially in the un-complexed form. Hence, complexation by spray
drying was found to be a highly efficient method to produce the carvedilol-b-cyclodex-
trin-citric acid ternary complex.
Differential scanning calorimetry
DSC was used to identify the inclusion ternary complex between the drug, b-cyclo-
dextrin and citric acid. As seen from Fig. 2a, the DSC thermogram of carvedilol alone
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Fig. 1. Phase solubility diagram
of carvedilol in solutions con-
taining: a) varying contreta-
tion of b-cyclodextrin () and
varying concentration of citric
acid containing 2 mmol L–1 of
b-cyclodextrin ().
showed a sharp endothermic peak at 118 °C, corresponding to the melting point of the
crystalline form of carvedilol. The physical mixture showed separate endotherms corre-
sponding to carvedilol (118 °C), citric acid (75–80 °C) and b-cyclodextrin, indicating no
complex formation. In case of the kneaded complex, a broad endotherm was obtained
around 120 °C. The thermogram of the inclusion ternary complex prepared by the spray
drying method shifted towards lower temperature showed a broad endotherm between
90 and 100 °C. Lower temperature of the inclusion ternary complex can be attributed to
the melting point depression in the complex. Similar conditions were found when felo-
dipine and carbamazepine were complexed with b-cyclodextrin, which resulted in the
lowering of the endothermic peak of the complexed drug (13). Also in the case of the
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Fig. 2. a) Differential scanning calorimetry, b) X-Ray powder diffraction patterns and c) FT-IR spec-
tra of: a – pure drug, b – physical mixture, c – complex obtained by kneading, d – complex obtained
by spray drying.
complex obtained by spray drying, it can be concluded that amorphization of the drug
occurred in the presence of b-cyclodextrin and citric acid and trapping of carvedilol in-
side the b-cyclodextrin cavity, leading to the broad nature of the endotherm.
Powder X-ray diffractometry
The PXRD graphs for pure drug, physical mixture, kneaded complex and complex
obtained by sprey drying are shown in Fig. 2b. Peaks for crystallinity were observed in
pure drug at 2q values of 6, 12, 14, 15, 18.5, 25, 27 and 28°. The PXRD of complexes pre-
pared by physical mixing and kneading revealed the presence of the uncomplexed crys-
talline nature of the drug. However, it was interesting to note that these peaks were sup-
pressed or absent in the complex obtained by spraying drying indicating amorphization
of the drug and complexation of carvedilol with b-cyclodextrin. These results of PXRD
were strongly supported by the above DSC observations.
Fourier transform infrared spectroscopy
Fig. 2c shows the infrared spectra of pure drug, physical mixture, kneaded complex
and ternary complex obtained by spray drying. Carvedilol showed characteristic peaks
at 3346.8 cm–1 (O-H and N-H stretching vibration peaks merged together), 2924.35 cm–1
(C-H stretching vibrations), 1591.42 cm–1 (N-H bending vibrations) and 1255.77 cm–1
(O-H bending and C-O stretching vibrations). The intensity and shape of these bands
changed dramatically for the inclusion ternary complex compared to the physical mix-
ture and pure drug. The complex showed broadening of O-H and N-H stretching vibra-
tions peaks (3383.45 cm–1). Differences were found in the 1480–1600 cm–1 region, which
were attributed to skeleton vibrations of the C=C bonds in the aromatic ring. In the low
frequency region (1000–400 cm–1), all the spectra were almost unchanged, indicating that
overall symmetry of the molecule was not significantly affected even though the vibration
and bending of the drug were restricted due to the formation of an inclusion complex.
Scanning electron microscopy
The microphotographs of pure drug, kneaded and spray dried ternary complex are
shown in Fig. 3. The pure drug appeared to be in the crystalline form. In case of the ter-
nary complex obtained by spray drying, significant changes in particle shape and sur-
face topography were observed. Particles appeared as irregularly shaped agglomerates
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a) b)
Fig. 3. Scanning elec-
tron microscope pho-
tographs: a) pure drug,
b) complex obtained
by spray drying.
with surface smoothness indicating an amorphous nature. These results support the PXRD
and DSC studies.
Saturation solubility of complexes
Saturation solubility of the pure drug and complexed drug prepared by different
methods in different buffer media is shown in Table II. Carvedilol is almost insoluble in
water, with saturation, solubility of (8.5 ± 2.6) ´ 10–3 mg mL–1. A significant increase
(110-fold) in solubility in distilled water was obtained in the case of the ternary complex
obtained by spray drying. This may be attributed to the formation of the ternary com-
plex of the drug with b-cyclodextrin and citric acid. Also, the spray-drying method has
greater efficiency for inclusion complex formation than the kneading method. It also re-
sulted in the amorphous nature of the complex, as evidenced in DSC, PXRD and SEM
studies. The saturation solubility of the spray dried drug was also determined and found
to be (9.2 ± 1.9) ´ 10–3 mg mL–1. Thus, mere spray drying of the drug does not bring
about an increase in solubility of the drug as obtained in the case of the ternary complex
obtained by spray drying.
Physical properties and dissolution of tablets
The tablets containing pure drug and the ternary complex obtained by kneading
and spray drying were prepared using the wet granulation technique. Tablets were ana-
lyzed for mass variation, friability, disintegration time and drug content (Table III). The
in vitro drug dissolution studies of the tablet with complexed carvedilol obtained by
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Distilled water 0.008 ± 0.003 0.092 ± 0.019 0.650 ± 0.090 0.927 ± 0.060
HCl (pH 1.2) 0.567 ± 0.028 0.548 ± 0.009 0.580 ± 0.075 0.614 ± 0.033
Acetate buffer (pH 4.5) 0.707 ± 0.044 0.826 ± 0.423 1.048 ± 0.016 1.329 ± 0.126
Simulated saliva (pH 6.2) 0.074 ± 0.003 0.076 ± 0.003 0.258 ± 0.092 0.433 ± 0.011
a Mean ± SD, n = 3.













Pure drug 151.7 ± 1.1 40.2 ± 2.2 0.719 22 102.7 ± 1.5
Complex obtained
by spray drying
150.8 ± 1.2 40.2 ± 2.0 0.068 24 96.3 ± 2.4
a Mean ± SD, n = 3.
spray drying and pure carvedilol tablet were carried out in distilled water (shown in
Fig. 4). A significant improvement in the dissolution profile of tablets prepared from the
carvedilol complex was observed as compared to the pure drug tablet. 100 and 30 % re-
lease, resp. was obtained in 5 minutes in the case of tablets with the complex and pure
drug tablets. These results support the saturation solubility study. Since 100 % drug re-
lease was achieved in 5 minutes this makes it suitable as a mouth-dissolving tablet.
Stability study
Stability studies were carried out for the tablets with the complex obtained by spray
drying by exposing them to 40 °C at 75 % relative humidity. Drug content, disintegration
time, dissolution, XRD and DSC studies were carried out at the end of 3 months and
compared to the day zero. No significant changes were observed in drug content, disso-
lution and disintegration of the tablet with the complex obtained by spray drying after 3
months.
Also, the PXRD and DSC patterns of the complex powder obtained by spray drying
recorded after 3 months gave identical patterns (data not shown) to the initial ones.
CONCLUSIONS
Phase solubility studies of carvedilol with b-cyclodextrin showed that the AN type
of curve was obtained, which indicated that the complex was formed in a 1:2 molar ra-
tio. Phase solubility of the drug with b-cyclodextrin and citric acid showed higher solu-
bilization efficiency. The ternary complex of carvedilol-b-cyclodextrin-citric acid was for-
med in a molar ratio of 1:2:2. Preparation of carvedilol-b-cyclodextrin-citric acid ternary
complex by spray drying resulted in effective complexation with significant improve-
ment in aqueous solubility compared to the physical mixture and kneaded complex. The
in vitro dissolution studies of the tablets prepared from the ternary complex of carvedilol
obtained by spray drying showed 100 % release in 5 minutes. In the stability study, no
significant changes were recorded with respect to XRD, DSC, drug content, disintegra-
tion and dissolution over a period of 3 months, indicating a stable complex. Since 100 %
release of the drug from the tablet was obtained within 5 minutes, the approach is suit-
able for the formulation of mouth-dissolving tablets of carvedilol.
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Fig. 4. Dissolution profile of the pure
drug tablet () and the tablet with
complex obtained by spray drying
() (mean ± SD, n = 6).
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S A  E T A K
Ternarna kompleksacija karvedilola, -ciklodekstrina i limunske kiseline
za razvoj tableta topljivih u ustima
VARSHA POKHARKAR, ABHISHEK KHANNA, VINOD VENKATPURWAR, SHEETAL DHAR i LEENATA MANDPE
Cilj rada bio je pobolj{ati topljivost i osloba|anje karvedilola stvaranjem ternarnog
kompleksa s b-ciklodekstrinom i limunskom kiselinom i razvoj tableta topljivih u ustima.
Takve tablete su napravljene s ciljem da se pobolj{a apsorpcija iz usta i izbjegne efekt
prvog prolaza, {to bi moglo imati za posljedicu pobolj{anu bioraspolo`ivost. Testovi
topljivosti pokazali su da b-ciklodekstrin i limunska kiselina stvaraju kompleks s kar-
vedilolom i zna~ajno pove}avaju njegovu topljivost. Ternarna kompleksacija karvedilola
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s b-ciklodekstrinom i limunskom kiselinom provedena je fizi~kim mije{anjem, gnje~enjem
i su{enjem raspr{ivanjem. Pripravljeni kompleksi karakterizirani su infracrvenom spek-
troskopijom, diferencijalnom pretra`nom kalorimetrijom, rendgenskom difraktometrijom
praha, pretra`nom elektronskom mikroskopijom i testovima u~inkovitosti kompleksa-
cije. Metodom su{enja raspr{ivanjem topljivost karvenidola pove}ala se 110 puta, a kom-
pleksacija je bila naju~inkovitija. Tablete pripravljene iz tog kompleksa i odgovaraju}ih
pomo}nih tvari potpuno su se otopile unutar pet minuta. Testovi ubrzanog starenja pro-
vedeni prema ICH smjernicama pokazali su da su tablete stabilne.
Klju~ne rije~i: karvedilol, ciklodekstrin, liminska kiselina, kompleksacija, topljivost, su{enje raspr{i-
vanjem, tablete topljive u ustima
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